mycobacterium tuberculosis antigen
Vaccineexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2006 (NCT00397943)
Timeline
Indications
Studied for
Mechanism of action
- Mycobacterium tuberculosisImmunity, active
Mycobacterium tuberculosis immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mycobacterium tuberculosis antigen
- mycobacterium tuberculosis vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03026972 | Phase 1 | Mar 15, 2017 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd., Fudan University, Government of China, People's Liberation Army of China |
| NCT00397943 | Phase 2 | Nov 1, 2006 | GlaxoSmithKline |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | For profit | 1 | 1 | 1 | 2017 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2017 |
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2006 |
| Government of China | Government | 1 | 0 | 1 | 2017 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2017 |
5 organizations
Page 1 / 1